Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Sintetica Limited, 30<sup>th</sup> Floor, 40 Bank Street, Canary Wharf, London, E14 5NR, United Kingdom
Ropivacaine 2 mg/ml solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear, colourless, sterile, isotonic, isobaric aqueous solution for infusion with a pH of 4.0 to 6.0. |
Each ml solution for infusion contains 2 mg ropivacaine hydrochloride.
Each 100 ml bag contains 200 mg ropivacaine hydrochloride.
Each 200 ml bag contains 400 mg ropivacaine hydrochloride.
Each 250 ml bag contains 500 mg ropivacaine hydrochloride.
Each 500 ml bag contains 1000 mg ropivacaine hydrochloride.
Excipient:
Each 100 ml bag contains 14.7 mmol (or 339 mg) of sodium.
Each 200 ml bag contains 29.5 mmol (or 678 mg) of sodium.
Each 250 ml bag contains 36.8 mmol (or 847.5 mg) of sodium.
Each 500 ml bag contains 73.6 mmol (or 1695 mg) of sodium.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ropivacaine |
Ropivacaine is a long-acting amide-type local anaesthetic with both anaesthetic and analgesic effects. At high doses ropivacaine produces surgical anaesthesia, while at lower doses it produces sensory block with limited and non-progressive motor block. |
| List of Excipients |
|---|
|
Sodium chloride |
Ropivacaine 2 mg/ml solution for infusion.
Polypropylene bags:
10 × 100ml, 20 × 100ml, 5 × 200 ml, 10 × 200ml, 20 × 200ml, 5 × 250 ml, 10 × 250ml, 20 × 250ml, 5 × 500 ml
Not all pack sizes may be marketed.
Sintetica Limited, 30th Floor, 40 Bank Street, Canary Wharf, London, E14 5NR, United Kingdom
PL 46926/0009
12/05/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
